NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球癌症病患註冊軟體市場(2021年∼2028年)

Global Cancer Registry Software Market - 2021-2028

出版商 DataM Intelligence 商品編碼 1008245
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
全球癌症病患註冊軟體市場(2021年∼2028年) Global Cancer Registry Software Market - 2021-2028
出版日期: 2021年05月27日內容資訊: 英文 180 Pages
簡介

癌症患者登記軟體是一個信息系統和計算機化數據庫,用於管理和收集與癌症患者相關的數據。登記的數據將被分析和評估並用於改善癌症患者的護理。癌症患者註冊軟體市場成長的主要因素有癌症發病率上升、市場友好型政府舉措、提高醫療保健質量的需要以及降低醫療保健成本的壓力越來越大。

本報告提供全球癌症病患註冊軟體市場調查,彙整市場概要,市場區隔·各地區的市場規模及成長率的變化與預測,新型冠狀病毒感染疾病(COVID-19)的影響分析,市場成長的推動要素及阻礙因素分析,市場機會,價格及貿易趨勢,競爭情形,主要企業簡介等資訊。

目錄

第1章 調查手法和範圍

  • 調查手法
  • 調查的目的和調查範圍

第2章 市場定義和概要

第3章 摘要整理

  • 市場明細:各類型
  • 市場明細:各部署模型
  • 市場明細:各資料庫
  • 市場明細:各終端用戶
  • 市場明細:各地區

第4章 市場動態

  • 市場影響要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 新型冠狀病毒感染疾病(COVID-19)的影響分析

  • 新型冠狀病毒感染疾病(COVID-19)的影響分析
    • COVID-19前的市場方案
    • 目前市場方案
    • COVID-19後的市場方案
  • COVID-19中的價格趨勢
  • 供需頻譜
  • 政府在COVID-19疫情下的市場相關措施
  • 製造商策略性舉措
  • 總論

第7章 全球癌症病患註冊軟體市場:各類型

  • 簡介
    • 市場規模·與前一年同期比較成長率分析:各類型
    • 市場魅力指數:各類型
  • 獨立型軟體
    • 簡介
    • 市場規模·成長率的分析與預測
  • 整合型軟體

第8章 全球癌症病患註冊軟體市場:各部署模型

  • 簡介
    • 市場規模·與前一年同期比較成長率分析:各部署模型
    • 市場魅力指數:各部署模型
  • 內部部署
    • 簡介
    • 市場規模·成長率的分析與預測
  • 雲端基礎

第9章 全球癌症病患註冊軟體市場:各資料庫

  • 簡介
    • 市場規模·與前一年同期比較成長率分析:各資料庫
    • 市場魅力指數:各資料庫
  • 商務用資料庫
    • 簡介
    • 市場規模·成長率的分析與預測
  • 公共資料庫

第10章 全球癌症病患註冊軟體市場:各終端用戶

  • 簡介
    • 市場規模·與前一年同期比較成長率分析:各終端用戶
    • 市場魅力指數:各終端用戶
  • 醫院
    • 簡介
    • 市場規模·成長率的分析與預測
  • 診療所
  • 門診外科中心

第11章 全球癌症病患註冊軟體市場:各地區

  • 簡介
    • 市場規模分析·與前一年同期比較成長率:各地區
    • 市場魅力指數:各地區
  • 北美
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各類型
    • 市場規模·與前一年同期比較成長率:各部署模型
    • 市場規模·與前一年同期比較成長率:各資料庫
    • 市場規模·與前一年同期比較成長率:各終端用戶
    • 市場規模·與前一年同期比較成長率:各國
  • 歐洲
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各類型
    • 市場規模·與前一年同期比較成長率:各部署模型
    • 市場規模·與前一年同期比較成長率:各資料庫
    • 市場規模·與前一年同期比較成長率:各終端用戶
    • 市場規模·與前一年同期比較成長率:各國
  • 南美
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各類型
    • 市場規模·與前一年同期比較成長率:各部署模型
    • 市場規模·與前一年同期比較成長率:各資料庫
    • 市場規模·與前一年同期比較成長率:各終端用戶
    • 市場規模·與前一年同期比較成長率:各國
  • 亞太地區
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各類型
    • 市場規模·與前一年同期比較成長率:各部署模型
    • 市場規模·與前一年同期比較成長率:各資料庫
    • 市場規模·與前一年同期比較成長率:各終端用戶
    • 市場規模·與前一年同期比較成長率:各國
  • 中東·非洲
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各類型
    • 市場規模·與前一年同期比較成長率:各部署模型
    • 市場規模·與前一年同期比較成長率:各資料庫
    • 市場規模·與前一年同期比較成長率:各終端用戶

第12章 競爭情形

  • 競爭模式
  • 市場定位/股票分析
  • 合併·收購分析

第13章 企業簡介

  • Siemens Healthineers
    • 企業概要
    • 產品系列
    • 主要的焦點
    • 財務形勢
  • Onco, Inc
  • C/Net Solutions
  • Elekta AB
  • Rocky Mountain Cancer Data Systems
  • Electronic Registry Systems, Inc
  • Mckesson Corporation
  • Ordinal Data, Inc
  • Conduent, Inc
  • IBM

第14章 關於DataM Intelligence

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Market Overview

The global cancer registry software market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

A cancer registry software is an information system or computerized database to manage and collect the data associated with cancer patients. This data helps in the evaluation of trends and eventually enhances cancer patient care. As per the World Health Organization, cancer killed about 9.6 million people in 2018. The data demonstrates the need for cancer registry software and has facilitated the expansion of the global cancer registry software market in the forecast period. Initiatives taken by governments to increase the use of cancer registries have also augmented the market's frontiers.

Market Dynamics

The cancer registry software market growth is driven by increasing prevalence of cancer and favorable government initiatives, rising pressure to improve the quality of care and reduce healthcare costs, increasing adoption of EHRs, and growing use of cancer patient registry data for post-marketing surveillance.

Rise in the adoption of electronic health records (EHR) has driven the market

The surge in the adoption of electronic health records (EHR) is the critical constituent promoting the development of the cancer registry software market. Moreover, healthcare professionals are focusing on increasing the quality of concern for cancer patients. It will only be accomplished by analyzing the trends repeatedly and taking actions accordingly, thereby increasing cancer registry software.

Governments of numerous countries are taking initiatives to encourage the adoption of the cancer registry software. In addition to this, customization of standard software for patient registries facilitating automatic upgradation and multiple system usage has spiked the global cancer registry system's market. The development of new cancer registry software has further supported the market's growth.

For instance, Elekta has developed a novel cancer registry data administration software called METRIC. It displays various functions such as workflow management, remote abstracting, data validation, and population and careful analysis. These functions are carried out in a 24/7 guarded data center using abstract configuration, follow-up manager. This tool has gained immense popularity in the global cancer registry market, mainly due to its ease of use. It offers simple navigation and efficient follow-up that includes status updates, history, schedules, control lists, and letters. Moreover, it has significantly reduced operating costs with the help of efficient workflow tools..

The availability of free software programs for cancer registry is driving the market growth

The availability of free software applications for cancer registries plays a crucial role in increasing the global cancer registry software market. Registry Plus is a suite of such free cancer registry software programs for individual or routine data collection. It includes a central registry database program called the CRS plus and a web application that collects cancer data across the internet. Moreover, it is submissive to the national standards, which has helped extensive adoption of this product.

Safety and privacy of the data may pose a challenge to the market's growth

Cancer patient registries include health report data that may include a broad array of demographic data and personal characteristics such as socioeconomic and marital status, formal education, developmental disabilities, cognitive capacities, emotional stability, gender, age, and race. Also, health data generally covers information about the patients' family members. As a result, in the circumstances of a data breach, the individual, confidential information of patients and third parties can come into the wrong hands. In the healthcare industry, ~30% of data breaks result in medical identity theft, mainly due to a lack of internal control over patient information, top management assistance, obsolete policies and schemes, non-adherence to existing ones, and inadequate resources personnel training. Governments of many countries in developed markets are currently trying to address and coordinate the consolidated needs of privacy and freedom of information.

COVID-19 Impact Analysis

Due to COVID, all the hospitals are given preference to the affected patients. Also, many hospitals are full due to the COVID-affected patients. The medical staff and paramedics are also busy in the treatment of COVID-positive patients. Thus there is a minimum use or no use of this software in the present situation. This factor will hamper the market growth in the forecast period.

Segment Analysis

By type, the cancer registry software market is classified into standalone software and integrated software.

Standalone Software segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

Standalone Software summarizes medical records into an electronic report of cancer diagnosis and treatment. It supports the abstraction of all data items in national standard data sets, including all text fields and any state-specific data items. Its output is an electronic abstract in the North American Association of Central Cancer Registries (NAACCR) data exchange layout format.

Central cancer registries can customize Abstract Plus to be used centrally and by hospitals, clinics, laboratories, and other cancer data sources. Clients should not make any changes (additions, modifications, deletions) to the database schema objects without written approval from CDC.

On the basis of database, the the cancer registry software market is classified into commercial databases amd public databases.

The commercial databases segment are expected to dominate the cancer registry software market during the forecast period

Commercial databases for cancer is has the larger share in the forecast period. The database sourced from hospital registry data that are collected in more than 1,500 Commission on Cancer (CoC)-accredited facilities. NCDB data are used to analyze and track patients with malignant neoplastic diseases, their treatments, and outcomes. Data represent more than 70 percent of newly diagnosed cancer cases nationwide and more than 34 million historical records. Online reporting tools are available to provide your program with comparative benchmarks for similar programs aggregated throughout your state, region, and across CoC-accredited programs as a whole. Additional reporting tools provide quality related performance measures in comparison to aggregated CoC-accredited programs, including quality improvement, quality assurance, and surveillance measures.

Geographical Analysis

North America region holds the largest market share in the global cancer registry software market

North America region is dominating the global cancer registry software market accounted for the largest market share in 2020. Factors such as the high burden of cancer, government funding initiatives to encourage the development of cancer registries, high investments in healthcare IT, the presence of significant cancer registry software development market players, and the high adoption rate of these solutions in the region are contributing to the larger share of North America in the cancer registry software market.

In the US, federal agencies such as the NIH, CDC, CMS, and AHRQ, along with several state agencies, are focusing on developing cancer patient registries to determine the long-term outcomes of agents, devices, groups of drugs, or procedures. The National Program of Cancer Registries (NPCR), administered by the US CDC, funded 50 cancer registries in the US in 2018 to promote the monitoring of the cancer burden at the state and national levels and evaluating activities in cancer prevention and control.

Competitive Landscape

The cancer registry software market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Siemens Healthineers , Onco, Inc, C/Net Solutions, Elekta AB, Rocky Mountain Cancer Data Systems, Electronic Registry Systems, Inc, Mckesson Corporation, Ordinal Data, Inc, Conduent, Inc, IBM, Himagine solutions inc among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the cancer registry software market globally.

Siemens Healthineers

Overview: Siemens Healthineers is a Germany-based company that provides technology to the healthcare sector companies. The Company has a wide range of products and services in laboratory and point of care diagnostics, diagnostic and therapeutic imaging and molecular medicine. It supplies medical technology and software solutions and clinical consulting services. Additionally, the Company is expanding its digital health and business services through increasing precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare to enable healthcare providers to increase value.

Product Portfolio: The Company's portfolio comprised of medical imaging, laboratory diagnostics, point-of-care testing, and Healthcare IT, accessories and equipment's, and other areas.

Why Purchase the Report?

  • Visualize the composition of the cancer registry software market segmentation by type, deployment model, database and end user highlighting the key commercial assets and players.
  • Identify commercial opportunities in cancer registry software market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of cancer registry software market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global cancer registry software market report would provide an access to an approx. 69 market data table, 60 figures and 200 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Cancer Registry Software Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Cancer Registry Software Market - Market Definition and Overview

3. Global Cancer Registry Software Market - Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Deployment Model
  • 3.3. Market Snippet by Database
  • 3.4. Market Snippet by End User
  • 3.5. Market Snippet by Region

4. Global Cancer Registry Software Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the adoption of electronic health records (EHR) has driven the market
      • 4.1.1.2. The availability of free software programs for cancer registry is driving the market growth
    • 4.1.2. Restraints:
      • 4.1.2.1. Safety and privacy of the data may pose a challenge to the market's growth
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Cancer Registry Software Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Cancer Registry Software Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Cancer Registry Software Market - By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Standalone Software*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Integrated Software

8. Global Cancer Registry Software Market - By Deployment Model

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Model
    • 8.1.2. Market Attractiveness Index, By Deployment Model
  • 8.2. On-premise*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Cloud-based

9. Global Cancer Registry Software Market - By Database

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Database
    • 9.1.2. Market Attractiveness Index, By Database
  • 9.2. Commercial Databases*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Public Databases

10. Global Cancer Registry Software Market - By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 10.3. Clinics
  • 10.4. Ambulatory Surgical Centers

11. Global Cancer Registry Software Market - By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Model
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Database
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Model
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Database
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Model
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Database
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Model
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Database
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Model
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Database
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Global Cancer Registry Software Market - Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Global Cancer Registry Software Market- Company Profiles

  • 13.1. Siemens Healthineers*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Onco, Inc
  • 13.3. C/Net Solutions
  • 13.4. Elekta AB
  • 13.5. Rocky Mountain Cancer Data Systems
  • 13.6. Electronic Registry Systems, Inc
  • 13.7. Mckesson Corporation
  • 13.8. Ordinal Data, Inc
  • 13.9. Conduent, Inc
  • 13.10. IBM

LIST NOT EXHAUSTIVE

14. Global Cancer Registry Software Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us